[1]
Gainetdinov RR, Hoener MC, Berry MD. Trace Amines and Their Receptors. Pharmacological reviews. 2018 Jul:70(3):549-620. doi: 10.1124/pr.117.015305. Epub
[PubMed PMID: 29941461]
[2]
Gillman PK. A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths. Journal of neural transmission (Vienna, Austria : 1996). 2018 Nov:125(11):1707-1717. doi: 10.1007/s00702-018-1932-y. Epub 2018 Sep 25
[PubMed PMID: 30255284]
[3]
Salter M, Kenney A. Myocardial Injury from Tranylcypromine-Induced Hypertensive Crisis Secondary to Excessive Tyramine Intake. Cardiovascular toxicology. 2018 Dec:18(6):583-586. doi: 10.1007/s12012-018-9476-9. Epub
[PubMed PMID: 30083815]
[4]
Berry MD, Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. Journal of neurochemistry. 2004 Jul;
[PubMed PMID: 15228583]
[5]
D'Andrea G,Terrazzino S,Fortin D,Farruggio A,Rinaldi L,Leon A, HPLC electrochemical detection of trace amines in human plasma and platelets and expression of mRNA transcripts of trace amine receptors in circulating leukocytes. Neuroscience letters. 2003 Jul 31;
[PubMed PMID: 12850555]
Level 3 (low-level) evidence
[6]
Varounis C, Katsi V, Nihoyannopoulos P, Lekakis J, Tousoulis D. Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature. Frontiers in cardiovascular medicine. 2016:3():51. doi: 10.3389/fcvm.2016.00051. Epub 2017 Jan 10
[PubMed PMID: 28119918]
[7]
Krishnan KR. Revisiting monoamine oxidase inhibitors. The Journal of clinical psychiatry. 2007:68 Suppl 8():35-41
[PubMed PMID: 17640156]
[8]
Yamada M, Yasuhara H. Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology. 2004 Jan:25(1-2):215-21
[PubMed PMID: 14697896]
[10]
Laranjo M, Potes ME, Elias M. Role of Starter Cultures on the Safety of Fermented Meat Products. Frontiers in microbiology. 2019:10():853. doi: 10.3389/fmicb.2019.00853. Epub 2019 Apr 26
[PubMed PMID: 31133993]
[11]
Tangwatcharin P, Nithisantawakhup J, Sorapukdee S. Selection of indigenous starter culture for safety and its effect on reduction of biogenic amine content in Moo som. Asian-Australasian journal of animal sciences. 2019 Oct:32(10):1580-1590. doi: 10.5713/ajas.18.0596. Epub 2019 Feb 7
[PubMed PMID: 30744331]
Level 3 (low-level) evidence
[12]
Ruiz-Capillas C, Herrero AM. Impact of Biogenic Amines on Food Quality and Safety. Foods (Basel, Switzerland). 2019 Feb 8:8(2):. doi: 10.3390/foods8020062. Epub 2019 Feb 8
[PubMed PMID: 30744001]
Level 2 (mid-level) evidence
[13]
Andersen G,Marcinek P,Sulzinger N,Schieberle P,Krautwurst D, Food sources and biomolecular targets of tyramine. Nutrition reviews. 2019 Feb 1;
[PubMed PMID: 30165672]
[14]
McCabe BJ. Dietary tyramine and other pressor amines in MAOI regimens: a review. Journal of the American Dietetic Association. 1986 Aug:86(8):1059-64
[PubMed PMID: 3525654]
[15]
D'Andrea G, Nordera GP, Perini F, Allais G, Granella F. Biochemistry of neuromodulation in primary headaches: focus on anomalies of tyrosine metabolism. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2007 May:28 Suppl 2():S94-6
[PubMed PMID: 17508188]
[16]
Ghose K, Coppen A, Carrol D. Intravenous tyramine response in migraine before and during treatment with indoramin. British medical journal. 1977 May 7:1(6070):1191-3
[PubMed PMID: 324566]
[17]
Trupin S, A perspective on the editorial by Ken Gillman: '"Much ado about nothing': monoamine oxidase inhibitors, drug interactions, and dietary tyramine''. CNS spectrums. 2017 Oct
[PubMed PMID: 28625201]
Level 3 (low-level) evidence
[18]
Carpéné C, Galitzky J, Belles C, Zakaroff-Girard A. Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food. Journal of physiology and biochemistry. 2018 Nov:74(4):623-633. doi: 10.1007/s13105-018-0643-z. Epub 2018 Jul 23
[PubMed PMID: 30039351]
[19]
Raiteri M, Del Carmine R, Bertollini A, Levi G. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. European journal of pharmacology. 1977 Jan 21:41(2):133-43
[PubMed PMID: 832672]
[20]
Brown C, Taniguchi G, Yip K. The monoamine oxidase inhibitor-tyramine interaction. Journal of clinical pharmacology. 1989 Jun:29(6):529-32
[PubMed PMID: 2666453]
[21]
Lindemann L,Hoener MC, A renaissance in trace amines inspired by a novel GPCR family. Trends in pharmacological sciences. 2005 May;
[PubMed PMID: 15860375]
[22]
Babusyte A, Kotthoff M, Fiedler J, Krautwurst D. Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. Journal of leukocyte biology. 2013 Mar:93(3):387-94. doi: 10.1189/jlb.0912433. Epub 2013 Jan 11
[PubMed PMID: 23315425]
[23]
Berry MD, Gainetdinov RR, Hoener MC, Shahid M. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges. Pharmacology & therapeutics. 2017 Dec:180():161-180. doi: 10.1016/j.pharmthera.2017.07.002. Epub 2017 Jul 16
[PubMed PMID: 28723415]
[24]
Bugda Gwilt K, González DP, Olliffe N, Oller H, Hoffing R, Puzan M, El Aidy S, Miller GM. Actions of Trace Amines in the Brain-Gut-Microbiome Axis via Trace Amine-Associated Receptor-1 (TAAR1). Cellular and molecular neurobiology. 2020 Mar:40(2):191-201. doi: 10.1007/s10571-019-00772-7. Epub 2019 Dec 13
[PubMed PMID: 31836967]
[25]
Smith SB,Maixner DW,Fillingim RB,Slade G,Gracely RH,Ambrose K,Zaykin DV,Hyde C,John S,Tan K,Maixner W,Diatchenko L, Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis and rheumatism. 2012 Feb;
[PubMed PMID: 21905019]
[26]
Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacology & therapeutics. 2010 Mar:125(3):363-75. doi: 10.1016/j.pharmthera.2009.11.005. Epub 2009 Dec 4
[PubMed PMID: 19948186]